Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
15.72
+0.07 (0.45%)
At close: Nov 13, 2026, 4:00 PM EST
15.78
+0.06 (0.40%)
After-hours: Nov 13, 2026, 7:30 PM EST
Rallybio Employees
Rallybio had 6 employees as of September 30, 2026. The number of employees decreased by 9 or 60.00% compared to the same quarter last year. That makes Rallybio the 41,614th largest employer in the world and 6,461st in the United States.
Employees
6
Change (1Y)
-9
Growth (1Y)
-60.00%
Revenue / Employee
$72,333
Profits / Employee
$4,468,333
Market Cap
84.64M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2026 | 6 | -9 | -60.00% |
| Jun 30, 2026 | 7 | -13 | -65.00% |
| Mar 31, 2026 | 9 | -15 | -62.50% |
| Dec 31, 2025 | 14 | -11 | -44.00% |
| Sep 30, 2025 | 15 | -10 | -40.00% |
| Jun 30, 2025 | 20 | -5 | -20.00% |
| Mar 31, 2025 | 24 | -6 | -20.00% |
| Dec 31, 2024 | 25 | -18 | -41.86% |
| Sep 30, 2024 | 25 | -19 | -43.18% |
| Jun 30, 2024 | 25 | -20 | -44.44% |
| Mar 31, 2024 | 30 | -13 | -30.23% |
| Dec 31, 2023 | 43 | 2 | 4.88% |
| Sep 30, 2023 | 44 | 0 | - |
| Jun 30, 2023 | 45 | 0 | - |
| Mar 31, 2023 | 43 | 3 | 7.50% |
| Dec 31, 2022 | 41 | 6 | 17.14% |
| Sep 30, 2022 | 44 | 13 | 41.94% |
| Jun 30, 2022 | 45 | 17 | 60.71% |
| Mar 31, 2022 | 40 | 12 | 42.86% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Coherus Oncology | 145 |
| Seer, Inc. | 124 |
| Cibus | 118 |
| Rani Therapeutics Holdings | 71 |
| Tenaya Therapeutics | 70 |
| Neumora Therapeutics | 63 |
| Corbus Pharmaceuticals Holdings | 36 |
| Genelux | 26 |
RLYB News
- 2 days ago - Correction to Press Release Announcing Reverse Stock Split of Rallybio Common Stock in Connection with the Proposed Merger with Avenzo - Business Wire
- 3 days ago - Rallybio announces one-for-two reverse stock split - TheFly
- 3 days ago - Rallybio Announces Reverse Stock Split of Common Stock in Connection with the Proposed Merger with Avenzo - Business Wire
- 7 days ago - Rallybio Corp trading halted, news pending - TheFly
- 9 days ago - Rallybio Transcript: AGM 2026 - Transcripts
- 17 days ago - Rallybio Quarterly report: Q3 2026 - Filings
- 3 months ago - Rallybio Quarterly report: Q2 2026 - Filings
- 5 months ago - Rallybio to acquire Avenzo Therapeutics through merger transaction - TheFly